Heron Therapeutics, Inc.
DE ˙ DB ˙ US4277461020
0,38 € ↓ -0,05 (-12,76%)
2026-06-04
AKTIENPREIS
SecurityDE:AXD2 / Heron Therapeutics, Inc.
InstitutionCitigroup Inc
Latest Disclosed Ownership7,240 shares
Latest Disclosed Value $ 5,793
Citigroup Inc ownership in AXD2 / Heron Therapeutics, Inc.

On May 11, 2026 - Citigroup Inc filed a 13F-HR form disclosing ownership of 7,240 shares of Heron Therapeutics, Inc. (DE:AXD2) valued at $4,695 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 3,478 shares of Heron Therapeutics, Inc.. This represents a change in shares of 108.17% during the quarter. The current value of the position is $2,722 USD.

Citigroup Inc has a history of taking positions in derivatives of the underlying security (AXD2) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD and put options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

DE:AXD2 / Heron Therapeutics, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-11 2026-03-31 13F HERON THERAPEUTICS COM 427746102 7,240 3,762 108.17 6 25.00 0.0000
2026-02-13 2025-12-31 13F HERON THERAPEUTICS COM 427746102 3,478 -2,473,051 -99.86 5 -99.87 0.0000
2025-11-10 2025-09-30 13F HERON THERAPEUTICS COM 427746102 2,476,529 2,424,576 4,666.86 3,120 2,815.89 0.0014
2025-08-11 2025-06-30 13F HERON THERAPEUTICS COM 427746102 51,953 -29,889 -36.52 108 -40.56 0.0001
2025-05-12 2025-03-31 13F HERON THERAPEUTICS COM 427746102 81,842 -9,172 -10.08 180 29.50 0.0001
2025-02-12 2024-12-31 13F HERON THERAPEUTICS COM 427746102 91,014 5,031 5.85 139 -18.71 0.0001
2024-11-12 2024-09-30 13F HERON THERAPEUTICS COM 427746102 85,983 35,503 70.33 171 -2.84 0.0001
2024-08-12 2024-06-30 13F HERON THERAPEUTICS COM 427746102 50,480 33,017 189.07 177 266.67 0.0001
2024-05-10 2024-03-31 13F HERON THERAPEUTICS COM 427746102 17,463 -977 -5.30 48 54.84 0.0000
2024-02-09 2023-12-31 13F HERON THERAPEUTICS COM 427746102 18,440 18,230 8,680.95 31 0.0000
2023-12-06 2023-09-30 13F/A-1 HERON THERAPEUTICS COM 427746102 210 -30,635 -99.32 0 -100.00 0.0000
2023-11-09 2023-09-30 13F HERON THERAPEUTICS COM 427746102 210 -30,635 0 0.0000
2023-08-10 2023-06-30 13F HERON THERAPEUTICS COM 427746102 30,845 20,412 195.65 36 133.33 0.0000
2023-05-11 2023-03-31 13F HERON THERAPEUTICS COM 427746102 10,433 -562 -5.11 16 -44.44 0.0000
2023-02-09 2022-12-31 13F HERON THERAPEUTICS COM 427746102 10,995 -546,097 -98.03 27 -98.85 0.0000
2022-11-10 2022-09-30 13F HERON THERAPEUTICS COM 427746102 557,092 -206,423 -27.04 2,351 10.38 0.0017
2022-08-10 2022-06-30 13F HERON THERAPEUTICS COM 427746102 763,515 612,908 406.96 2,130 147.39 0.0016
2022-05-12 2022-03-31 13F HERON THERAPEUTICS COM 427746102 150,607 -290,077 -65.82 861 -78.60 0.0005
2022-02-10 2021-12-31 13F HERON THERAPEUTICS COM 427746102 440,684 244,403 124.52 4,023 91.66 0.0022
2021-11-10 2021-09-30 13F HERON THERAPEUTICS COM 427746102 196,281 -100,996 -33.97 2,099 -54.51 0.0012
2021-08-10 2021-06-30 13F HERON THERAPEUTICS COM 427746102 297,277 50,038 20.24 4,614 15.15 0.0028
2021-05-13 2021-03-31 13F HERON THERAPEUTICS COM 427746102 247,239 226,115 1,070.42 4,007 796.42 0.0026
2021-02-11 2020-12-31 13F HERON THERAPEUTICS COM 427746102 21,124 15,114 251.48 447 402.25 0.0003
2020-11-12 2020-09-30 13F HERON THERAPEUTICS COM 427746102 6,010 -54,896 -90.13 89 -90.07 0.0001
2020-08-12 2020-06-30 13F HERON THERAPEUTICS COM 427746102 60,906 -1,491 -2.39 896 22.24 0.0007
2020-05-12 2020-03-31 13F HERON THERAPEUTICS COM 427746102 62,397 18,324 41.58 733 -29.25 0.0007
2020-02-12 2019-12-31 13F HERON THERAPEUTICS COM 427746102 44,073 -102,745 -69.98 1,036 -61.86 0.0008
2019-11-08 2019-09-30 13F HERON THERAPEUTICS COM 427746102 146,818 -76,788 -34.34 2,716 -34.66 0.0022
2019-08-12 2019-06-30 13F HERON THERAPEUTICS COM 427746102 223,606 209,439 1,478.36 4,157 1,101.45 0.0034
2019-05-13 2019-03-31 13F HERON THERAPEUTICS COM 427746102 14,167 -119,403 -89.39 346 -90.01 0.0003
2019-02-12 2018-12-31 13F HERON THERAPEUTICS COM 427746102 133,570 129,411 3,111.59 3,465 2,545.04 0.0035
2018-11-13 2018-09-30 13F HERON THERAPEUTICS COM 427746102 4,159 -31,155 -88.22 131 -90.45 0.0001
2018-08-10 2018-06-30 13F HERON THERAPEUTICS COM 427746102 35,314 -220,595 -86.20 1,372 -80.57 0.0013
2018-05-11 2018-03-31 13F HERON THERAPEUTICS COM 427746102 255,909 -381,135 -59.83 7,063 -38.74 0.0058
2018-02-12 2017-12-31 13F HERON THERAPEUTICS COM 427746102 637,044 -103,615 -13.99 11,530 -3.61 0.0092
2017-11-13 2017-09-30 13F HERON THERAPEUTICS COM 427746102 740,659 -331,969 -30.95 11,962 -19.47 0.0098
2017-08-11 2017-06-30 13F HERON THERAPEUTICS COM 427746102 1,072,628 1,034,218 2,692.57 14,855 2,474.52 0.0134
2017-05-12 2017-03-31 13F HERON THERAPEUTICS COM 427746102 38,410 -176,173 -82.10 577 -79.47 0.0005
2017-02-10 2016-12-31 13F HERON THERAPEUTICS COM 427746102 214,583 204,593 2,047.98 2,810 1,533.72 0.0025
2016-11-10 2016-09-30 13F HERON THERAPEUTICS COM 427746102 9,990 -1,357 -11.96 172 -16.10 0.0002
2016-08-12 2016-06-30 13F HERON THERAPEUTICS COM 427746102 11,347 -11,264 -49.82 205 -52.21 0.0002
2016-05-13 2016-03-31 13F HERON THERAPEUTICS COM 427746102 22,611 14,925 194.18 429 109.27 0.0005
2016-02-12 2015-12-31 13F HERON THERAPEUTICS COM 427746102 7,686 -71,036 -90.24 205 -89.32 0.0002
2015-11-13 2015-09-30 13F HERON THERAPEUTICS COM 427746102 78,722 75,181 2,123.16 1,920 1,645.45 0.0018
2015-08-13 2015-06-30 13F HERON THERAPEUTICS COM 427746102 3,541 -202 -5.40 110 103.70 0.0001
2015-05-14 2015-03-31 13F HERON THERAPEUTICS COM 427746102 3,743 -2,631 -41.28 54 -15.62 0.0001
2015-02-17 2014-12-31 13F HERON THERAPEUTICS COM 427746102 6,374 5,528 653.43 64 814.29 0.0001
2014-11-14 2014-09-30 13F HERON THERAPEUTICS COM 427746102 846 641 312.68 7 133.33 0.0000
2014-08-14 2014-06-30 13F HERON THERAPEUTICS COM 427746102 205 136 197.10 3 200.00 0.0000
2014-05-15 2014-03-31 13F HERON THERAPEUTICS COM 427746102 69 69 1 0.0000
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2020-08-12 2020-06-30 13F HERON THERAPEUTICS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2020-05-12 2020-03-31 13F HERON THERAPEUTICS COM Call 1,800 -91.18 21 -95.62 n/a n/a n/a
2020-02-12 2019-12-31 13F HERON THERAPEUTICS COM Call 20,400 -19.69 479 1.91 n/a n/a n/a
2019-11-08 2019-09-30 13F HERON THERAPEUTICS COM Call 25,400 31.61 470 30.92 n/a n/a n/a
2019-08-12 2019-06-30 13F HERON THERAPEUTICS COM Call 19,300 56.91 359 19.27 n/a n/a n/a
2019-05-13 2019-03-31 13F HERON THERAPEUTICS COM Call 12,300 339.29 301 312.33 n/a n/a n/a
2019-02-12 2018-12-31 13F HERON THERAPEUTICS COM Call 2,800 -85.26 73 -87.85 n/a n/a n/a
2018-11-13 2018-09-30 13F HERON THERAPEUTICS COM Call 19,000 -1.55 601 -19.87 n/a n/a n/a
2018-08-10 2018-06-30 13F HERON THERAPEUTICS COM Call 19,300 2.66 750 44.51 n/a n/a n/a
2018-05-11 2018-03-31 13F HERON THERAPEUTICS COM Call 18,800 -70.11 519 -54.39 n/a n/a n/a
2018-02-12 2017-12-31 13F HERON THERAPEUTICS COM Call 62,900 60.05 1,138 79.21 n/a n/a n/a
2017-11-13 2017-09-30 13F HERON THERAPEUTICS COM Call 39,300 257.27 635 317.76 n/a n/a n/a
2017-08-11 2017-06-30 13F HERON THERAPEUTICS COM Call 11,000 4.76 152 -3.80 n/a n/a n/a
2017-05-12 2017-03-31 13F HERON THERAPEUTICS COM Call 10,500 425.00 158 507.69 n/a n/a n/a
2017-02-10 2016-12-31 13F HERON THERAPEUTICS COM Call 2,000 -74.03 26 -80.45 n/a n/a n/a
2016-11-10 2016-09-30 13F HERON THERAPEUTICS COM Call 7,700 -35.83 133 -38.71 n/a n/a n/a
2016-08-12 2016-06-30 13F HERON THERAPEUTICS COM Call 12,000 -19.46 217 -23.32 n/a n/a n/a
2016-05-13 2016-03-31 13F HERON THERAPEUTICS COM Call 14,900 58.51 283 12.75 n/a n/a n/a
2016-02-12 2015-12-31 13F HERON THERAPEUTICS COM Call 9,400 -86.30 251 -85.01 n/a n/a n/a
2015-11-13 2015-09-30 13F HERON THERAPEUTICS COM Call 68,600 1,674 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2020-08-12 2020-06-30 13F HERON THERAPEUTICS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2020-05-12 2020-03-31 13F HERON THERAPEUTICS COM Put 8,400 -22.94 99 -61.33 n/a n/a n/a
2020-02-12 2019-12-31 13F HERON THERAPEUTICS COM Put 10,900 81.67 256 130.63 n/a n/a n/a
2019-11-08 2019-09-30 13F HERON THERAPEUTICS COM Put 6,000 -72.48 111 -72.59 n/a n/a n/a
2019-08-12 2019-06-30 13F HERON THERAPEUTICS COM Put 21,800 -13.15 405 -33.93 n/a n/a n/a
2019-05-13 2019-03-31 13F HERON THERAPEUTICS COM Put 25,100 340.35 613 314.19 n/a n/a n/a
2019-02-12 2018-12-31 13F HERON THERAPEUTICS COM Put 5,700 -28.75 148 -41.50 n/a n/a n/a
2018-11-13 2018-09-30 13F HERON THERAPEUTICS COM Put 8,000 -23.08 253 -37.38 n/a n/a n/a
2018-08-10 2018-06-30 13F HERON THERAPEUTICS COM Put 10,400 -44.97 404 -22.61 n/a n/a n/a
2018-05-11 2018-03-31 13F HERON THERAPEUTICS COM Put 18,900 67.26 522 154.63 n/a n/a n/a
2018-02-12 2017-12-31 13F HERON THERAPEUTICS COM Put 11,300 48.68 205 66.67 n/a n/a n/a
2017-11-13 2017-09-30 13F HERON THERAPEUTICS COM Put 7,600 744.44 123 925.00 n/a n/a n/a
2017-08-11 2017-06-30 13F HERON THERAPEUTICS COM Put 900 -73.53 12 -76.47 n/a n/a n/a
2017-05-12 2017-03-31 13F HERON THERAPEUTICS COM Put 3,400 -48.48 51 -40.70 n/a n/a n/a
2017-02-10 2016-12-31 13F HERON THERAPEUTICS COM Put 6,600 -37.14 86 -52.49 n/a n/a n/a
2016-11-10 2016-09-30 13F HERON THERAPEUTICS COM Put 10,500 -30.46 181 -33.70 n/a n/a n/a
2016-08-12 2016-06-30 13F HERON THERAPEUTICS COM Put 15,100 277.50 273 259.21 n/a n/a n/a
2016-05-13 2016-03-31 13F HERON THERAPEUTICS COM Put 4,000 -11.11 76 -36.67 n/a n/a n/a
2016-02-12 2015-12-31 13F HERON THERAPEUTICS COM Put 4,500 -96.00 120 -95.63 n/a n/a n/a
2015-11-13 2015-09-30 13F HERON THERAPEUTICS COM Put 112,400 2,743 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.